UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.363

Sortiert nach

Reduction of the renal uptake of radiolabeled monoclonal antibody fragments by cationic amino acids and their derivatives

Cancer research (Chicago, Ill.), 1995-09, Vol.55 (17), p.3825-3834

1995

Volltextzugriff (PDF)

Tumor-specific dose scheduling of bimodal radioimmunotherapy and chemotherapy

Anticancer research, 2003-11, Vol.23 (6C), p.4613

2003

Volltextzugriff (PDF)

Celecoxib exhibits the greatest potency amongst cyclooxygenase (COX) inhibitors for growth inhibition of COX-2-negative hematopoietic and epithelial cell lines

Cancer research (Chicago, Ill.), 2002-04, Vol.62 (7), p.2029-2033

2002

Volltextzugriff (PDF)

Degranulating Eosinophils in Human Endometriosis

The American journal of pathology, 2000-05, Vol.156 (5), p.1581-1588

2000

Volltextzugriff (PDF)

Colonic Tumor CEA, CSAp and MUC-1 Expression following Radioimmunotherapy or Chemotherapy

Tumor biology, 2003-01, Vol.24 (1), p.32-39

2003

Volltextzugriff (PDF)

Experimental studies on the role of antibody fragments in cancer radio‐immunotherapy: Influence of radiation dose and dose rate on toxicity and anti‐tumor efficacy

International journal of cancer, 1998-08, Vol.77 (5), p.787-795

1998

Volltextzugriff (PDF)

Regulation of tumour drug delivery by blood flow chronobiology

European journal of cancer (1990), 2000-09, Vol.36 (14), p.1876-1884

2000

Volltextzugriff (PDF)

Anti‐oxidant vitamins reduce normal tissue toxicity induced by radio‐immunotherapy

International journal of cancer, 2000-04, Vol.86 (2), p.276-280

2000

Volltextzugriff (PDF)

Improved treatment of medullary thyroid cancer in a nude mouse model by combined radioimmunochemotherapy : Doxorubicin potentiates the therapeutic efficacy of radiolabeled antibodies in a radioresistant tumor type

Cancer research (Chicago, Ill.), 1997-12, Vol.57 (23), p.5309-5319

1997

Volltextzugriff (PDF)

Plasma FLT3‐L levels predict bone marrow recovery from myelosuppressive therapy

Cancer, 2000-01, Vol.88 (2), p.333-343

2000

Volltextzugriff (PDF)

Response to Radioimmunotherapy Correlates with Tumor pO2 Measured by EPR Oximetry in Human Tumor Xenografts

Radiation research, 2001-03, Vol.155 (3), p.466-473

2001

Volltextzugriff (PDF)

In vitro and in vivo anticancer efficacy of unconjugated humanized anti-CEA monoclonal antibodies

British journal of cancer, 2008-09, Vol.99 (5), p.837-838

2008

Volltextzugriff (PDF)

Advantage of residualizing radiolabels for an internalizing antibody against the B-cell lymphoma antigen, CD22

Cancer Immunology, Immunotherapy, 1997-05, Vol.44 (3), p.179-188

1997

Volltextzugriff (PDF)

Carcinoembryonic antigen antibody inhibits lung metastasis and augments chemotherapy in a human colonic carcinoma xenograft

Cancer Immunology, Immunotherapy, 2005-04, Vol.54 (4), p.315-327

2005

Volltextzugriff (PDF)

Comparison of equitoxic radioimmunotherapy and chemotherapy in the treatment of human colonic cancer xenografts

Cancer research (Chicago, Ill.), 1994, Vol.54 (1), p.142-151

1994

Volltextzugriff (PDF)

Cure of Metastatic Human Colonic Cancer in Mice with Radiolabeled Monoclonal Antibody Fragments

Clinical cancer research, 2000-12, Vol.6 (12), p.4900-4907

2000

Volltextzugriff (PDF)

Dose Escalation of Radioantibody in a Mouse Model With the Use of Recombinant Human Interleukin-1 and Granulocyte-Macrophage Colony-Stimulating Factor Intervention to Reduce Myelosuppression

JNCI : Journal of the National Cancer Institute, 1992-03, Vol.84 (6), p.399-407

1992

Volltextzugriff (PDF)

Quantitative and qualitative effects of experimental radioimmunotherapy on tumor vascular permeability

International journal of cancer, 1995-05, Vol.61 (4), p.557-566

1995

Volltextzugriff (PDF)

Myelosuppressive changes from single or repeated doses of radioantibody therapy: effect of bone marrow transplantation, cytokines, and hematopoietic suppression

Experimental hematology, 1998-08, Vol.26 (9), p.859

1998

Volltextzugriff (PDF)

The presence of a concomitant bulky tumor can decrease the uptake and therapeutic efficacy of radiolabeled antibodies in small tumors

International journal of cancer, 1992-05, Vol.51 (3), p.470-475

1992

Volltextzugriff (PDF)

Application of cytokine intervention for improved radio‐antibody dose delivery

International journal of cancer, 1997-07, Vol.72 (1), p.166-173

1997

Volltextzugriff (PDF)

Defining the optimal spacing between repeat radioantibody doses in experimental models is there an accurate measurement for hematopoietic recovery?

Cancer, 1997-12, Vol.80 (12), p.2624-2635

1997

Volltextzugriff (PDF)

The effect of antibody protein dose on the uniformity of tumor distribution of radioantibodies : an autoradiographic study

Cancer Immunology Immunotherapy, 1991-11, Vol.33 (6), p.351-358

1991

Volltextzugriff (PDF)

Selection of radioimmunoconjugates for the therapy of well‐established or micrometastatic colon carcinoma

International journal of cancer, 1997-07, Vol.72 (3), p.477-485

1997

Volltextzugriff (PDF)

Reduction in the duration of myelotoxicity associated with radioimmunotherapy with infusions of the hemoregulatory peptide, HP5b in mice

International journal of cancer, 1997-01, Vol.70 (3), p.323-329

1997

Volltextzugriff (PDF)

1 – 25 von 1.363

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.168)
Mit Volltextzugriff
(1.181)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(857)
Life Sciences & Biomedicine
(719)
Humans
(650)
Female
(421)
Biological And Medical Sciences
(376)
Male
(349)
Medical Sciences
(303)
Middle Aged
(265)
Adult
(219)
Animals
(179)
Aged
(167)
Cardiovascular System & Cardiology
(133)
Cardiac & Cardiovascular Systems
(117)
Risk Factors
(106)
Physical Sciences
(99)
Fundamental And Applied Biological Sciences. Psychology
(85)
Mice
(82)
Cardiology. Vascular System
(77)
General & Internal Medicine
(75)
Adolescent
(70)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Reduction of the renal uptake of radiolabeled monoclonal antibody fragments by cationic amino acids and their derivatives

Tumor-specific dose scheduling of bimodal radioimmunotherapy and chemotherapy

Celecoxib exhibits the greatest potency amongst cyclooxygenase (COX) inhibitors for growth inhibition of COX-2-negative hematopoietic and epithelial cell lines

Degranulating Eosinophils in Human Endometriosis

Colonic Tumor CEA, CSAp and MUC-1 Expression following Radioimmunotherapy or Chemotherapy

Experimental studies on the role of antibody fragments in cancer radio‐immunotherapy: Influence of radiation dose and dose rate on toxicity and anti‐tumor efficacy

Regulation of tumour drug delivery by blood flow chronobiology

Anti‐oxidant vitamins reduce normal tissue toxicity induced by radio‐immunotherapy

Improved treatment of medullary thyroid cancer in a nude mouse model by combined radioimmunochemotherapy : Doxorubicin potentiates the therapeutic efficacy of radiolabeled antibodies in a radioresistant tumor type

Plasma FLT3‐L levels predict bone marrow recovery from myelosuppressive therapy

Response to Radioimmunotherapy Correlates with Tumor pO2 Measured by EPR Oximetry in Human Tumor Xenografts

In vitro and in vivo anticancer efficacy of unconjugated humanized anti-CEA monoclonal antibodies

Advantage of residualizing radiolabels for an internalizing antibody against the B-cell lymphoma antigen, CD22

Carcinoembryonic antigen antibody inhibits lung metastasis and augments chemotherapy in a human colonic carcinoma xenograft

Comparison of equitoxic radioimmunotherapy and chemotherapy in the treatment of human colonic cancer xenografts

Cure of Metastatic Human Colonic Cancer in Mice with Radiolabeled Monoclonal Antibody Fragments

Dose Escalation of Radioantibody in a Mouse Model With the Use of Recombinant Human Interleukin-1 and Granulocyte-Macrophage Colony-Stimulating Factor Intervention to Reduce Myelosuppression

Quantitative and qualitative effects of experimental radioimmunotherapy on tumor vascular permeability

Myelosuppressive changes from single or repeated doses of radioantibody therapy: effect of bone marrow transplantation, cytokines, and hematopoietic suppression

The presence of a concomitant bulky tumor can decrease the uptake and therapeutic efficacy of radiolabeled antibodies in small tumors

Application of cytokine intervention for improved radio‐antibody dose delivery

Defining the optimal spacing between repeat radioantibody doses in experimental models is there an accurate measurement for hematopoietic recovery?

The effect of antibody protein dose on the uniformity of tumor distribution of radioantibodies : an autoradiographic study

Selection of radioimmunoconjugates for the therapy of well‐established or micrometastatic colon carcinoma

Reduction in the duration of myelotoxicity associated with radioimmunotherapy with infusions of the hemoregulatory peptide, HP5b in mice

Suchergebnisse filtern